Literature DB >> 19121802

Do abandoned leads pose risk to implantable cardioverter-defibrillator patients?

Michael Glikson1, Mahmoud Suleiman, David M Luria, Marjorie L Martin, David O Hodge, Win-Kuang Shen, David J Bradley, Thomas M Munger, Robert F Rea, David L Hayes, Stephen C Hammill, Paul A Friedman.   

Abstract

BACKGROUND: With the increased number of implantable cardioverter-defibrillator (ICD) recipients and the frequent need for device upgrading, lead malfunction is a concern, but the optimal approach to managing nonfunctioning leads is unknown.
OBJECTIVE: The purpose of this study was to determine the rate and characteristics of complications related to abandoned ICD leads.
METHODS: Patients with abandoned leads were identified by retrospective review of the Mayo Clinic ICD database from August 1993 to May 2002. We reviewed the medical records to assess long-term follow-up for venous thromboembolic complications, device sensing malfunction, appropriateness of delivered shocks, defibrillation threshold (DFT) values before and after lead abandonment, and subsequent surgical procedures related to devices or leads.
RESULTS: We identified 78 ICD patients (81% males; mean age 63 +/- 14 years) with 101 abandoned leads (69 in the right ventricle, 31 in the right atrium or superior vena cava, 1 in the coronary sinus). During a mean follow-up of 3.1 +/- 2.0 years, neither sensing malfunction nor venous thromboembolic complications were detected. DFT values were high in 13 patients (17%), but there was no significant increase in mean DFT values before and after lead abandonment in 43 patients for whom both values were available (16.2 +/- 9.2 J before abandonment vs 14.1 +/- 5.5 J after; P = .24). Fourteen patients (18%) required further ICD-related surgery; none of these operations were attributed to abandoned leads. Five-year rates of appropriate and inappropriate shocks were 25.9% and 20.5%, respectively.
CONCLUSION: Abandoning a nonfunctioning lead appears to be safe and does not pose a clinically significant additional risk of future complications.

Entities:  

Mesh:

Year:  2008        PMID: 19121802     DOI: 10.1016/j.hrthm.2008.10.012

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  12 in total

Review 1.  Considerations for cardiac device lead extraction.

Authors:  Oussama Wazni; Bruce L Wilkoff
Journal:  Nat Rev Cardiol       Date:  2016-01-29       Impact factor: 32.419

2.  Cardiac resynchronization therapy in patients undergoing open-chest cardiac surgery.

Authors:  Alberto Barosi; Maurizio Lunati; Giancarlo Speca; Alessandro Mazzola; Gabriele Paglino; Michele De Bonis; Saverio Iacopino; Mauro Cassese; Cosimo Damiano Dicandia; Giampiero Esposito; Marco Vimercati; Alberto Della Scala; Ettore Vitali
Journal:  J Interv Card Electrophysiol       Date:  2010-03-10       Impact factor: 1.900

3.  Outcomes 1 Year After Implantable Cardioverter-Defibrillator Lead Abandonment Versus Explantation for Unused or Malfunctioning Leads: A Report from the National Cardiovascular Data Registry.

Authors:  Emily P Zeitler; Yongfei Wang; Kumar Dharmarajan; Kevin J Anstrom; Eric D Peterson; James P Daubert; Jeptha P Curtis; Sana M Al-Khatib
Journal:  Circ Arrhythm Electrophysiol       Date:  2016-07

Review 4.  A Questionable Indication For ICD Extraction After Successful VT Ablation.

Authors:  Luca Segreti; Andrea Di Cori; Giulio Zucchelli; Ezio Soldati; Giovanni Coluccia; Stefano Viani; Luca Paperini; Maria Grazia Bongiorni
Journal:  J Atr Fibrillation       Date:  2015-04-30

5.  Consequences of Retained Defibrillator and Pacemaker Leads After Heart Transplantation-An Underrecognized Problem.

Authors:  Luise Holzhauser; Teruhiko Imamura; Hemal M Nayak; Nitasha Sarswat; Gene Kim; Jayant Raikhelkar; Sara Kalantari; Amit Patel; David Onsager; Tae Song; Takeyoshi Ota; Valluvan Jeevanandam; Gabriel Sayer; Nir Uriel
Journal:  J Card Fail       Date:  2018-01-08       Impact factor: 5.712

6.  Right ventricular lead induced ventricular arrhythmia-A rare complication of cardiac resynchronization therapy.

Authors:  Dawid Miśkowiec; Paweł Życiński; Dariusz H Qawoq; Piotr Pagórek; Piotr Zając; Michał Chudzik; Tomasz Wcisło; Jarosław D Kasprzak
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-06-26       Impact factor: 1.468

7.  Extraction of chronically implanted cardiovascular electronic device leads.

Authors:  Jeffrey Brinker
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-08

8.  Managing patients with advisory defibrillator leads: what can we learn from published data?

Authors:  F A Bracke; B M van Gelder
Journal:  Neth Heart J       Date:  2015-04       Impact factor: 2.380

9.  Long-Range Real Migration of Implantable Cardioverter Defibrillator Lead.

Authors:  Andreas Keyser; Harald Brodoefel; Christof Schmid
Journal:  Thorac Cardiovasc Surg Rep       Date:  2015-11-24

10.  Significance of intraoperative testing in right-sided implantable cardioverter-defibrillators.

Authors:  Andreas Keyser; Michael K Hilker; Ekrem Ucer; Sigrid Wittmann; Christof Schmid; Claudius Diez
Journal:  J Cardiothorac Surg       Date:  2013-04-11       Impact factor: 1.637

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.